How A Pandemic Pushed The Gas Pedal On Patient Centricity In Clinical Trials
By Jennifer Duff, General Manager, Clinical Development Solutions
![GettyImages-1313298867 cancer patient GettyImages-1313298867 cancer patient](https://vertassets.blob.core.windows.net/image/7654430f/7654430f-8ce7-4647-9026-641f21ae7f95/375_250-gettyimages_1313298867_cancer_patient.jpg)
Scientific research is challenging. Scientific research on human beings is even more challenging. Factor in a global pandemic that altered nearly every form of human interaction, and you have the perfect storm to drive the clinical trial industry to change course. The good news — perhaps one of the few silver linings to emerge from the COVID-19 pandemic — is that this has largely been a change for the better. Clinical trials are quickly becoming more participant-friendly (and more provider-friendly) through the broader adoption of digital technologies.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.